Telomir Pharmaceuticals, Inc.
TELO
$1.22
$0.032.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.72M | -990.90K | -2.06M | -1.10M | -5.07M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 786.50K | 39.80K | -7.90K | 98.10K | 4.66M |
| Change in Net Operating Assets | -77.30K | -822.40K | 867.80K | 76.90K | -291.00K |
| Cash from Operations | -1.01M | -1.77M | -1.20M | -927.30K | -696.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 0.00 | 224.80K | 155.50K | -- | -- |
| Total Debt Repaid | -66.50K | -177.40K | -- | -- | -- |
| Issuance of Common Stock | 6.30K | -- | 1.00M | 7.50M | 1.05M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 682.30K | -- | -- | -- | -- |
| Cash from Financing | 622.10K | 47.40K | 1.16M | 7.50M | 1.05M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -390.20K | -1.73M | -42.60K | 6.58M | 351.30K |